Top pharmaceutical company evaluates Optimer for precision liver medicine

The Optimer delivery vehicle was developed to selectively target cells linked to fibrotic liver disease, as part of a fee-for-service partnership with the pharmaceutical company that began in 2020. Subsequent work at Aptamer Group combining the Optimer with a model gene therapy payload has shown that the Optimer enables selective delivery of the gene therapy

Forecasting The Future: 11 Analyst Projections For Ultragenyx Pharmaceutical

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $82.55, along with a high estimate of $114.00 and a low estimate of $48.00. This upward trend is evident, with the current average reflecting a 6.93% increase from the previous average price target of $77.20.

MBK Partners acquires pharmaceutical wholesaler Geo-Young from Blackstone

Largest M&A deal so far this yearMBK Partners has acquired a major stake in pharmaceutical wholesaler Geo-Young, strengthening the private equity’s health care-focused investment portfolio. The deal is also the largest acquisition transaction on the domestic M&A market this year so far.

Pharmaceutical eCommerce Market Surging: Predicted 14.4% CAGR by 2034

The pharmaceutical eCommerce market is estimated to be valued at US$ 75,527.4 million in 2024. The market is projected to expand at a CAGR of 14.4% over the forecast period. The market report further predicts the net worth of the pharmaceutical eCommerce industry to be around US$ 290,